Form 4: Alignment Healthcare CEO Sells Shares

Sentiment:

Insider Transaction (Form 4)


John E Kao, Chief Executive Officer and a Director of Alignment Healthcare, Inc., sold 298,000 shares of common stock on July 10, 2026.

Summary

  • Open-market sale: disposed of 279,644 Common Stock at $19.81 ($5,540,363) on July 10, 2026; holds 1,107,122 after (Indirect).
  • Open-market sale: disposed of 18,356 Common Stock at $20.65 ($378,998) on July 10, 2026; holds 1,088,766 after (Indirect).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,919,361 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

John E Kao — Director, Officer (Chief Executive Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-07-10Open-market saleCommon Stock279,644$20$5.5M1,107,122
2026-07-10Open-market saleCommon Stock18,356$21$379.0K1,088,766

Key Dates

DateDescription
2026-07-10Open-market sale (279,644 shares)
2026-07-10Open-market sale (18,356 shares)

Keywords

insider transaction, Form 4, ALHC, Alignment Healthcare, Inc., bearish, John E Kao

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.